Next-generation sequencing-based HPV genotyping assay validated in formalin-fixed, paraffin-embedded oropharyngeal and cervical cancer specimens

Journal of Biomolecular Techniques

Volumn 27, Issue 2, 2016, Pages 46-52

  Ambulos, Nicholas P ^a   Schumaker, Lisa M ^a   Mathias, Trevor J ^a   White, Ruth ^a   Troyer, Jennifer ^b   Wells, David ^b   Cullen, Kevin J ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

Head and neck cancer; Human papillomavirus; Viral

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLUOROMETRY; GENOTYPING TECHNIQUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEXT GENERATION SEQUENCING; OROPHARYNX CANCER; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; WART VIRUS; DNA SEQUENCE; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN PAPILLOMAVIRUS TYPE 16; ISOLATION AND PURIFICATION; OROPHARYNGEAL NEOPLASMS; TISSUE FIXATION; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

FORMALDEHYDE; PARAFFIN; VIRUS DNA;

DNA, VIRAL; FEMALE; FORMALDEHYDE; GENOTYPING TECHNIQUES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMAN PAPILLOMAVIRUS 16; HUMANS; OROPHARYNGEAL NEOPLASMS; PARAFFIN EMBEDDING; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TISSUE FIXATION; UTERINE CERVICAL NEOPLASMS;

EID: 84977581410     PISSN: 15240215     EISSN: 19434731     Source Type: Journal    
DOI: 10.7171/jbt.16-2702-004     Document Type: Article

References (24)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350.
3. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956.
4. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
5. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013; 31: 4550-4559.
6. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
7. Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS, Huh W. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U. S. screening population: data from the ATHENA trial. Gynecol Oncol 2015; 137: 47-54.
8. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475.
9. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2012; 100B: 255-313.
10. Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O'Sullivan B, Kenny LM, McArthur GA. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02. 02 phase III trial. J Clin Oncol 2010; 28: 4142-4148.
11. Mellin Dahlstrand H, Lindquist D, Björnestål L, Ohlsson A, Dalianis T, Munck-Wikland E, Elmberger G. P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res 2005; 25: 4375-4383.
12. Liu SZ, Zandberg DP, Schumaker LM, Papadimitriou JC, Cullen KJ. Correlation of p16 expression and HPV type with survival in oropharyngeal squamous cell cancer. Oral Oncol 2015; 51: 862-869.
13. Schlecht NF, Brandwein-Gensler M, Nuovo GJ, Li M, Dunne A, Kawachi N, Smith RV, Burk RD, Prystowsky MB. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol 2011; 24: 1295-1305.
14. Chernock RD, Zhang Q, El-Mofty SK, Thorstad WL, Lewis JS Jr. Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans. Arch Otolaryngol Head Neck Surg 2011; 137: 163-169.
15. Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison MI. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol 2012; 36: 945-954.
16. Westra WH. Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol 2014; 50: 771-779.
17. Binnicker MJ, Pritt BS, Duresko BJ, Espy MJ, Grys TE, Zarka MA, Kerr SE, Henry MR. Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal Thin Prep Preserv Cyt samples and correlation with biopsy results. J Clin Microbiol 2014; 52: 3763-3768.
18. Black CC, Bentley HA, Davis TH, Tsongalis GJ. Use of a linear array for the detection of human papillomavirus genotypes in head and neck cancer. Arch Pathol Lab Med 2010; 134: 1813-1817.
19. Zandberg DP, Liu S, Goloubeva OG, Schumaker LM, Cullen KJ. Emergence of HPV16-positive oropharyngeal cancer in black patients over time: University of Maryland 1992-2007. Cancer Prev Res (Phila) 2015; 8: 12-19.
20. Lou H, Villagran G, Boland JF, Im KM, Polo S, Zhou W, Odey U, Juárez-Torres E, Medina-Martínez I, Roman-Basaure E, Mitchell J, Roberson D, Sawitzke J, Garland L, Rodríguez-Herrera M, Wells D, Troyer J, Castillo Pinto F, Bass S, Zhang X, Castillo M, Gold B, Morales H, Yeager M, Berumen J, Alvirez E, Gharzouzi E, Dean M. Genome analysis of Latin American cervical cancer: frequent activation of the PIK3CA pathway. Clin Cancer Res 2015; 21: 5360-5370.
21. Canadian Women's HIV Study Group. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the linear array HPV genotyping test. J Clin Microbiol 2006; 44: 1998-2006.
22. Schmitt M, Dondog B, Waterboer T, Pawlita M. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol 2008; 46: 1050-1059.
23. Breese MR, Liu Y. NGSUtils: a software suite for analyzing and manipulating next-generation sequencing datasets. Bioinformatics 2013; 29: 494-496.
24. Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, Bosch FX, de Sanjosé S, Trottier H. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol 2014; 15: 1319-1331.